Troikaa Pharma launches IV infusion system

Ahmedabad-based Rs 75-crore Troikaa Pharmaceuticals has launched an infusion system under the brand name of 'Accuflow' for the domestic market. The company also plans to make it available to more than 35 countries worldwide.

Accuflow is an infusion system with an in-built microprocessor that measures the infusion flow rates in terms of drops per minute or ml per hour along with the total volume infused.

The device's technology is compatible with all standard IV and micro IV sets.

Speaking on the occasion, Ketan Patel, managing director, Troikaa Pharmaceuticals, said, "The infusion system is unique as it will prove to be economically viable as well as user-friendly. We would be launching 'Accuflow' in 35-plus countries".

The device was conceptualised by Sanjeev Gokhale, an engineer by profession, and was identified by Centre for Innovation Incubation and Entrepreneurship (CIIE) at Indian Institute of Management, Ahmedabad (IIMA), under their national search for innovation programme.

It was further developed by Troikaa Pharma.

The device was evaluated on 116 patients at different levels of IV infusion therapy at AIIMS' Indian Spinal Injuries Centre and Delhi Pain Management Centre at New Delhi.

The device was also evaluated on 35 patients at Gujarat Cancer & Research Institute (GCRI).